Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    12476646 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Virtual Histology Findings and Effects of Varying Doses of Atorvastatin Treatment
Conditions: Coronary Disease;   Ultrasonography, Interventional;   Hydroxymethylglutaryl-CoA Reductase Inhibitors
Intervention: Drug: Atorvastatin 10mg versus 40mg.
2 Enrolling by invitation Atherosclerosis in High Risk Population Groups: An Assessment by Magnetic Resonance Imaging
Condition: Atherosclerosis
Intervention: Drug: Rosuvastatin 20 mg, Aspirin 81 mg

Indicates status has not been verified in more than two years